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Summary  Image-guided  percutaneous  transthoracic  core  biopsy  especially  with
CT  guidance  is  playing  an  increasing  role  in  the  diagnosis  and  management  of  lung
cancer.  The  recent  advances  in  the  speciﬁc  chemotherapy  and  novel  targeted  ther-
apy  and  the  increasing  need  for  speciﬁc  diagnosis  of  tumor  histopathologic  subtypes
have  direct  impact  on  the  radiologists  performing  lung  biopsy  and  important  implica-
tions  for  the  biopsy  technique.  Close  cooperation  between  radiologists  and  referring
physicians  with  understanding  of  the  technical  aspects  of  the  biopsy  procedure  can
help  clinicians  make  appropriate  referrals  for  this  procedure  and  understand  the  sig-
niﬁcance  and  limitations  of  the  results.  Additionally,  the  appropriate  management
of  complications  can  limit  morbidity  related  to  the  biopsy  procedure.
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ntroduction
ercutaneous  transthoracic  core  biopsy  is  an
ccepted  and  widely  used  method  of  establishing
he etiology  of  lung  masses.  It  is  thought  to  have
een developed  by  Leyden  in  1883  in  order  to  diag-
ose pneumonia.  The  technique  was  extended  to
he diagnosis  of  cancer  from  the  1930s  onwards  [1].
he development  of  high  resolution  imaging  modal-
ties, biopsy  needle  designs  and  cytologic  methods
ave  a  direct  impact  on  radiologists  performing  lung
iopsies and  have  led  to  more  widespread  use  of  the
echnique afterwards.
Patients  with  suspected  lung  cancer  need  a tis-
ue diagnosis,  which  can  be  obtained  with  either
 ﬁne-needle  aspiration  technique  or  core  biopsy,
roviding  cytological  and  histopathologic  speci-
ens,  respectively.  The  recent  advances  in  the
peciﬁc  chemotherapy  and  novel  targeted  therapy
2] and  the  increasing  need  for  speciﬁc  diagnosis
f tumor  histopathologic  subtypes  and  molecu-
ar markers  [3]  have  led  to  increasing  need  for
ore amount  of  tissue.  Compared  with  aspiration
ytology, core  biopsy  is  preferred  and  superior  to
spiration  because  it  can  obtain  multiple  larger
amples  for  both  cytological  and  histological  diag-
osis [3,4]  and  molecular  analysis  [5,6].  Many
adiologists  around  the  world  are  well  trained  in
btaining  ﬁne-needle  aspiration  of  lung  lesions.
owever,  core  biopsy  requires  careful  manipula-
ion and  special  attention  to  prevent  or  reduce
rocedure related  complications.  In  this  article,
e share  our  experience,  concepts  and  techniques
egarding image-guided  percutaneous  transtho-
acic lung  biopsy  with  emphasis  on  CT  guidance  and
oaxial technique  for  obtaining  core  biopsies  of  lung
esions.
ndications
s  with  any  interventional  procedure,  the  potential
eneﬁts  of  core  biopsy  must  outweigh  the  risks;  and
n each  case  the  technique  should  be  considered
ikely to  affect  patient  management.  Typically,  per-
utaneous transthoracic  core  biopsy  is  performed
n patient  with  indeterminate  pulmonary  nodule
r mass  to  conﬁrm  or  refute  the  presence  of
alignancy, and  where  malignancy  is conﬁrmed,  to
haracterize  the  tumor  further.  Other  indications
a
n
a
e cancer  S23
nclude  mediastinal  mass,  pulmonary  nodules  with
 known  extrathoracic  malignancy,  perihilar  mass
fter failed  or  negative  bronchoscopy,  postopera-
ive or  postradiation  changes,  suspected  recurrent
isease  and  infectious  consolidation.
ontraindications
revious  pneumonectomy  and  other  instances  of
 single  lung,  suspected  hydatid  cyst  or  vascu-
ar malformation  are  absolute  contraindications  to
ercutaneous  transthoracic  lung  biopsy.  Relative
ontraindications  include  coagulopathy,  antico-
gulant  therapy,  signiﬁcant  pulmonary  arterial
ypertension,  severe  lung  disease  (respiratory  fail-
re —  mechanical  ventilation,  severe  obstructive
ung disease,  and  severe  emphysematous  disease),
arge bullae,  or  inability  of  the  patient  to  cooper-
te.
maging modality of guidance
he  percutaneous  transthoracic  core  biopsy  of  lung
esions can  be  performed  using  ﬂuoroscopic,  ultra-
ongoraphic  (US)  or  computed  tomography  (CT)
uidance.  Choice  of  the  imaging  modality  is  deter-
ined  by  the  size  and  location  of  the  lesion,
vailability of  imaging  systems,  and  local  expertise
nd preference.  Chest  CT  is  required  prior  to  the
iopsy to  determine  the  biopsy  technique  as  the
esion depth  and  its  relation  to  ribs,  mediastinum,
ssures and  vessels  can  be  determined  to  plan  a
iopsy route  and  technique  [7].
Fluoroscopy  has  represented  the  historic  and  tra-
itional imaging  modality  for  percutaneous  biopsy
8,9]. Its  main  advantages  are  low  cost,  short  pro-
edure time,  and  real-time  visualization  of  the
eedle advancement.  It  can  be  used  for  the  periph-
ral and  large  lesions.  However,  the  disadvantages
f ﬂuoroscopy  include  difﬁculty  in  accessing  cen-
ral lesions  and  avoidance  of  bullae  and  vascular
tructures in  the  needle  pass  [9,10].  Although  ﬂu-
roscopy is  available  in  most  institutes,  it  is  used
ess frequently  at  present.
US is  most  often  used  imaging  modality  for
ccessing the  peripheral,  pleural-based  lesions  pro-
ucing acoustic  window  as  ultrasound  beam  does
ot pass  through  air.  It  allows  real-time  visual-
zation  with  multiplanar  capability  of the  needle
dvancement,  allowing  accurate  placement  of  the
eedle [11,12].  It  is  a  safe  with  no  radiation,  quick,
nd low-cost  modality  [11].  It  should  be  used  when-
ver possible  and  appropriate  [13].
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CT  is  the  preferred  and  most  common  used  guid-
ance modality.  It  is  the  standard  imaging  modality
for guidance  in  many  institutions  as  it  reveals  the
anatomic  structures  and  characterizes  the  lesion.
It permits  planning  a  trajectory  that  minimize
passage through  aerated  lung,  bullae,  ﬁssures  or
vessels and  that  allows  possible  access  to  central
lesions.  Additionally,  it  has  the  capability  to  distin-
guish necrotic  from  solid  portions  of  the  lesion  and
to document  unequivocally  the  needle  tip  within
the lesion,  a  point  of  major  value  in  the  inter-
pretation of  absence  of  malignant  cells  [14].  The
recent advances  in  spiral  CT  and  ﬂuoroscopy  CT
permit to  biopsy  smaller  lesion  and  perform  the  pro-
cedure more  quickly  in  less  cooperative  patients
[8,15—20]. Reported  accuracy  rates  for  percuta-
neous transthoracic  CT-guided  biopsies  range  from
64% to  97%  [21—24].  A  meta-analysis  of  19  stud-
ies showed  an  overall  sensitivity  of  90%  (95%  CI,
0.88—0.92)  for  biopsy  of  pulmonary  lesions  [25].  A
trend toward  lower  diagnostic  accuracy  was  noted
for lesions  with  less  the  1.5  cm  in  diameter  [23].
Needles
Numerous  types  of  biopsy  needles  with  various
sizes, tip  designs  and  sampling  mechanisms  have
been used  in  percutaneous  transthoracic  core
biopsy of  the  lung  [8].  An  ideal  biopsy  needle  should
minimize  pneumothorax  and  bleeding  complica-
tions and  maximize  the  tissue  specimen  obtained.
In our  practice,  we  use  automated  cutting  nee-
dles to  obtain  sufﬁcient  tissue  amount  free  of  crush
injury  for  histologic  evaluation.  Two  types  of  auto-
mated cutting  core  biopsy  needles  have  been  used.
They include  side-notch  needle  and  end-cut  nee-
dle. Choice  between  these  two  types  is generally  a
matter of  preference  and  availability.
The end-cut  design  has  several  advantages.  Most
importantly,  a  full  cannular  width  of  tissue  is
obtained  as  the  entire  lumen  and  almost  the  whole
length  of  advancement  of  the  needle  within  the
lesion is used  to  enclose  the  specimen.  In  the  side-
notch biopsy  needle,  the  actual  length  of  the  side
notch (i.e.  specimen)  is  shorter  than  the  advance-
ment  of  the  needle  as  only  part  of  the  needle  lumen
(i.e. the  volume  of  the  notch)  is used  to  have  tissue
[26].
Yet another  distinction  between  the  types  of
needles  is  related  to  the  technique  used  for  obtain-
ing the  biopsy  as  coaxial  and  single  shaft  (non
coaxial). Each  technique  has  certain  advantages
compared to  the  other.  However,  there  is  no  proof
that any  type  of  technique  is  superior  to  other  types
p
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n  terms  of  diagnostic  yield  and  complication  rate
8]. Using  the  coaxial  technique,  the  needle  will
e more  stable  in  the  chest  wall  and  multiple  sam-
les can  be  obtained  with  a  single  pleural  puncture
hich  helps  in  improving  the  diagnostic  yield  and
educing  the  risk  of  pneumothorax  especially  with
maller  diameter  needle  [27].  The  advantage  of  the
ingle needle  is  that  it  is  more  ﬂexible.  This  may
elp in  guiding  the  needle  to  the  correct  location.
The continued  reﬁnements  in  needle  design
ppear to  be  potential  for  improved  sensitivity  and
peciﬁcity  for  both  benign  and  malignant  diagnosis
28,29].
iopsy procedure
lanning
fter  consideration  of  the  patient  history  and  indi-
ations for  the  biopsy,  an  informed  consent  is
btained  from  the  patient  and  the  family.  The  con-
ent should  include  the  discussion  of  the  potential
isks and  beneﬁts  in  details.
The baseline  chest  CT  images  are  carefully
eviewed and  the  procedure  is planned  based  on
he size  and  location  of  the  lesion,  availability  of
maging systems,  and  local  expertise.
The needle  path  is  chosen  considering  straight
athway from  the  skin  to  lesion.  Ideally,  the  nee-
le should  cross  the  pleura  at  a 90-degree  angle
ather  than  at  an  oblique  angle.  The  pathway  should
void transversal  of  bullae,  vessels  and  bronchi.  The
nterlobar ﬁssures  are  avoided  usually  as  the  more
leural surfaces  that  are  crossed,  the  higher  the  risk
f pneumothorax.  In  case  of  more  than  one  lesion  is
resent, the  more  peripheral  lesion  is  chosen  over
 deep  lesion  because  less  lung  will  be  traversed,
ecreasing the  risk  of  complications.  A  lesion  in  an
pper lobe  is  preferred  over  one  in  a lower  lobe
ecause of  less  respiratory  excursion  in  the  upper
obes.  Necrotic  portions  of  lesions  are  avoided  due
o its  low  diagnostic  value  and  tendency  to  bleed
ore  than  intact  tumor.
atient positioning
atient  position  is  an  important  factor  in  improving
he accuracy  and  safety  of  the  lung  biopsy.  Consid-
ration  of  position  should  be  made  during  biopsy
lanning  as  the  patient  should  maintain  the  same
osition  throughout  the  entire  procedure.
If the  target  nodule  is  equally  accessible  from
ither prone,  supine,  or  decubitus  positioning,  the
rone position  is  ideal  due  to  its  association  with
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cmage-guided  percutaneous  transthoracic  biopsy  in
he  least  amount  of  chest  wall  motion  compared
ith the  supine  and  decubitus  positions.  Addition-
lly,  it  allows  a  more  comfortable  ‘‘biopsy  side
own’’  supine  position  during  recovery,  which  may
educe the  chance  of  developing  a  pneumotho-
ax. Moreover,  the  prone  position  prevents  the
atient  from  seeing  the  biopsy  needle  and  that  may
educes both  patient  anxiety  and  patient  move-
ent.  The  supine  position  is  associated  with  a
oderate  amount  of  chest  wall  motion,  whereas
he decubitus  position  is  associated  with  the  great-
st amount  of  chest  wall  motion
edation
edation  and  intravenous  analgesic  medications  are
sually not  required  with  the  liberal  use  of chest
all local  anesthetic.  The  pain  associated  with  the
rocedure  is usually  limited  and  momentary,  and
rises from  administration  of  the  local  anesthetic
nd violation  of  the  parietal  pleura  with  the  needle.
he burning  sensation  resulting  from  the  admin-
stration  of  local  anesthetic  can  be  reduced  with
dding  sodium  bicarbonate  to  raise  the  pH  of  local
nesthetic.
However,  patients  differ  in  their  ability  to  tol-
rate the  procedure  without  sedation,  which  may
ower the  patient’s  level  of  cooperation.  Seda-
ion and  analgesia  are  primarily  used  for  anxious
nd uncooperative  patients,  selected  elderly  peo-
le who  have  osteoarthritis  or  degenerative  joint
isease  and  cannot  maintained  raised  arms,  lesions
dherent  to  periosteum  and  chest  wall  or  when  the
rocedure  is lengthy.
T scan parameters
he  parameters  are  related  to  choice  of  tube  cur-
ent (mA)  and  slice  thickness.  Generally,  the  lowest
ose that  allows  for  evaluation  of  the  needle  in  rela-
ion to  the  nodule  is  required.  Most  of  modern  CT
canners  allow  a  routine  low-dose  axial  scan  with
20 kVp  and  40  mA  or  lower  per  slice.  Radiation  dose
eduction  is  important  because  it  is  often  necessary
o perform  multiple  images  through  the  same  tissue
olume  during  the  course  of  the  procedure.
The  slice  thickness  is  generally  chosen  in  rela-
ion to  the  size  of  the  nodule.  The  slice  thickness
hould be  less  than  half  the  diameter  of  the  tar-
eted lesion  in  order  to  be  certain  that  a  single
T image  contains  the  lesion.  In  this  way  con-
iguous slices  will  include  at  least  one  image  that
ontains  no  partial  volume  effects.  As  a  rule  of
humb for  choosing  slice  thickness,  the  follow-
ng slice  thicknesses  are  chosen;  one  centimeter
r 5  mm  for  lesions  >  3 cm  in  diameter,  5 mm  for
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esion 1—3  cm  in  diameter,  3  mm  for  lesions  <  1  cm
n diameter.  A  slice  thickness  of  1  mm  then  should
e chosen  for  ﬁnal  localization  of  the  needle
ip.
iopsy process
fter  appropriate  patient  positioning,  a  radiopaque
arker or  grid  is  placed  on  the  patient’s  skin  over
he area  of  interest.  During  suspended  respiration,
 short  CT  scan  of  the  region  of  interest  is obtained,
ollowed by  choosing  the  appropriate  table  position
nd needle  trajectory  as  previously  planned.  The
epth from  the  skin  entry  site  to  the  lesion  is  then
easured.
With the  use  of  the  gantry  laser  light  to  delineate
he Z-axis  position,  and  the  radiopaque  skin  marker
o reference  the  X-axis  position,  the  needle  entry
ite is  marked  with  indelible  ink  on  the  patient’s
kin. The  skin  site  is  prepped  and  draped  using  ster-
le technique  followed  by  administration  of  local
nesthesia  into  the  skin,  subcutaneous  tissues,  and
ntercostal muscles.
In  our  institute,  the  standard  practice  is to
se coaxial  technique  for  the  advantage  explained
efore. We  use  a  17-  or  19-guage  introducer  nee-
le as  guidance  with  appropriate  length  depending
n the  depth  of  lesion.  The  automated  cutting  nee-
le, which  can  be  any  needle  type,  is  chosen  to  be
maller and  to  matches  the  introducer  needle  in
ength and  size  to  be  18-  or  20-guage.
All needle  movements  and  manipulations  should
e performed  with  patient’s  respiration  suspended.
hen advancing  the  introducer  needle,  it  is  impor-
ant to  maintain  the  same  trajectory  with  each
ovement,  as  even  slight  deviations  of  the  needle
t the  skin  or  within  the  subcutaneous  tissues  will
roduce marked  deviation  at  a deeper  level.  When
dvancing  the  needle  into  the  subplural  region,  it
hould be  done  in  a rapid  thrust  to  avoid  needle
ip laceration  to  the  pleura  and  to  avoid  the  nee-
le slipping  into  the  pleural  during  breathing  later.
dditionally,  the  patient  is instructed  to  breath  qui-
tly, remain  motionless,  and  repeat  a breath  hold  of
 similar  size  during  needle  manipulations  through-
ut the  procedure.  The  needle  should  be  allowed
o sway  to-and-fro  with  respiratory  motion;  not  be
eld or  ﬁxed  during  respiration,  as  this  will  lacerate
he pleura  with  each  breath.
As needle  insertion  is  considered  a dynamic  pro-
ess from  skin  to  the  lesion;  a short  segment  CT
hould performed  always  to  verify  the  needle  angle
nd tip  position  based  on  the  last  scan  (a sequen-
ial technique).  The  needle  is  then  advanced  in  one
otion through  the  pleura  to  the  prescribed  depth.
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A  smaller  automated  cutting  needle  is  passed
through the  lumen  of  the  larger  introducer  nee-
dle and  into  the  lesion.  The  entire  needle  shaft
should be  within  the  scan  plane.  If  not,  addi-
tional images  above  or  below  the  entry  site  must
be obtained.  The  key  to  recognizing  the  true  tip
of the  needle  is  the  identiﬁcation  of  an  abrupt
square tip  with  a  black  shadowing  artifact  aris-
ing from  it  [30].  After  needle  tip  position  at  the
periphery  of  or  within  the  lesion  is  conﬁrmed  and
documented,  a  tissue  sample  can  be  obtained  with
ﬁring the  needle  into  the  lesion  during  suspended
respiration.
Postbiopsy scanning  can  help  in  localizing  the
biopsy direction  by  visualizing  the  small  hemor-
rhage in  most  cases  caused  by  the  shock  wave  of
the automated  cutting  needle  [31].
Most  operators  perform  at  least  two  biopsies
but more  can  be  obtained  based  on  the  lesion
characteristic. It is  important  when  using  coaxial
technique  to  leave  always  the  inner  stylet  inside
the entry  needle  as  if  the  tip  was  in  a  small  branch
of a  pulmonary  vein,  it  may  cause  devastating  air
embolism  [32].
In  our  institution,  the  standard  practice  is  to
seal the  biopsy  needle  track  with  a  hydrogel  plug
when removing  the  introducer  needle  to  prevent
the air  leaks  and  pneumothorax  [33].  As  per  manu-
facturer’s  instructions,  the  introducer  needle  tip  is
positioned at  deeper  level  to  the  visceral  pleura.  A
hydrogel plug  is  advanced  into  the  introducer  nee-
dle which  is  then  removed,  leaving  the  plug  behind
at the  predetermined  depth  to  expand  upon  con-
tact with  moist  tissue  and  ﬁll  the  track.  The  seal
is airtight.  The  hydrogel  plug  resorbs  into  the  body
over time.
Post-biopsy care
After  the  biopsy  is  complete,  a  short  CT  scan  is
performed  to  evaluate  patients  for  immediate  com-
plications.  If  the  scan  is  normal  with  no  signiﬁcant
pneumothorax  and  the  patient  is  asymptomatic,  the
patient is  transported  on  a  gurney  to  the  designated
area for  monitoring  by  the  assigned  medical  staff.
The patient  should  remain  recumbent  throughout
the monitoring  period.
Follow-up  expiratory  chest  radiographs  are
obtained with  sitting  upright  at  1—2  h  after  biopsy.
If the  chest  radiograph  shows  no  new  changes,  the
patient is  discharged.  Upon  discharge,  the  patient  is
asked to  abstain  from  strenuous  or  weight-bearing
activities for  3  days.  Additionally,  anticoagulants,
antiplatelets and  non-steroidal  anti-inﬂammatory
drugs are  not  allowed.
a
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omplications
ercutaneous  transthoracic  core  biopsy  of  the  lung
s generally  associated  with  higher  complication
ates compared  to  solid  organ  biopsy.  Based  on
ublished  guidelines  by  the  Society  of  Interven-
ional Radiology,  the  overall  complication  rate  of
ercutaneous  transthoracic  lung  biopsies  of  10%
ith threshold  success  rate  of 85%  are  accept-
ble [34].  Most  complications  occur  immediately
r within  the  ﬁrst  hour  of  a  biopsy  and  they
an be  treated  conservatively;  often  on  an  outpa-
ient  basis  [35—37].  Common  complications  include
neumothorax  and  hemorrhage.  Rare  complications
nclude air  embolism,  vasovagal  reaction,  cardiac
amponade,  and  seeding  of  the  tract  with  tumor.
neumothorax
neumothorax  after  CT-guided  percutaneous  lung
iopsy has  been  reported  from  8  to  54%,  with  an
verage  of  around  20%  in  most  large  series  as  CT
maging  can  detect  even  very  small  pneumothorax
hat may  not  even  be  visible  on  chest  radiograph.
owever, the  rate  for  pneumothoraces  requiring
reatment with  chest  tube  varies  from  5 to  18%
10,35,37—47]. Pneumothorax  can  occur  during  or
mmediately  after  the  procedure,  which  is  why  it
s important  to  perform  a CT  scan  of  the  region
ollowing removal  of  the  needle.
Risk factors  of  pneumothorax  after  lung  biopsy
ave been  identiﬁed  in  the  literature  with  a lot
f controversy.  The  suggested  main  factors  inﬂu-
ncing the  incidence  of  pneumothorax  are  lesion
ize [42,43],  lesion  depth  [42,44],  contact  with  the
leura [23],  the  presence  of  emphysema  on  CT,
ransgression  of  ﬁssures,  a small  angle  of  the  needle
ith the  thoracic  pleura,  and  multiple  repositioning
f the  needle  [48,49].
Various  techniques  have  been  proposed  to
educe the  incidence  of  a  signiﬁcant  pneumoth-
rax but  their  true  efﬁcacy  remains  unclear  and
one of  them  has  found  widespread  acceptance
46,50—53]. Recently,  a  prospective,  multicen-
er, randomized,  controlled  clinical  study  of  using
n expanding  hydrogel  lung  biopsy  tract  plug
n patients  undergoing  CT-guided  percutaneous
ransthoracic  lung  biopsy  has  shown  signiﬁcant
eduction in  the  rates  of  pneumothorax,  chest  tube
lacement  and  post-procedure  hospital  admission
33].Pneumothorax  that  is  small  (<20%  lung  volume),
symptomatic and  stable  does  not  require  treat-
ent and  conservative  management  is  appropriate.
he pneumothorax  must  be  treated  when  it  is
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tmage-guided  percutaneous  transthoracic  biopsy  in
ymptomatic,  its  size  exceeds  30%  of  the  lung
olume, and/or  its  size  continues  to  increase.
reatment starts  with  administrating  supplemental
asal oxygen  and  positioning  biopsy  side-down  if
ossible. If  the  biopsy  needle  is  still  within  the  tho-
ax, manual  aspiration  of  the  pneumothorax  can  be
ttempted  [37,54].  If  the  biopsy  needle  has  been
emoved  and  the  pneumothorax  is  large  or  symp-
omatic,  emergent  percutaneous  decompression
ith a  needle  or  catheter  is  necessary.  Choosing  a
mall-bore  or  large  bore  catheter  depends  on  the
neumothorax  size.  As  an  expiratory  upright  chest
adiograph  is  usually  obtained  immediately  after
iopsy as  a  baseline,  serial  chest  radiographs  are
btained to  observe  for  the  recurrence  of  pneu-
othorax.  An  unchanged  small  pneumothorax  at
 h  post-biopsy  is  unlikely  to  become  larger  [55].
f the  chest  radiographs  at  2  and  4 h  post-biopsy
how a  stable  small  or  decreasing  pneumothorax
nd the  patient  is  asymptomatic,  the  patient  can
e discharged  in  accordance  with  institutional  pol-
cy. Management  speciﬁcs  vary  by  institution,  but
ood communication  with  the  referring  clinician  or
ppropriate  inpatient  service  regarding  patient  sta-
us and  disposition  is  vital  [56].
emorrhage
emorrhage  is  the  second  most  common  and  the
ost dangerous  potential  complication  of  per-
utaneous  transthoracic  lung  biopsy.  At  least  to
ome extent,  every  percutaneous  transthoracic
ung biopsy  is  associated  with  some  degree  of  hem-
rrhage.  However,  it  is  most  often  self-limited  and
esolves spontaneously  without  treatment.  It may
ccur with  or  without  hemoptysis.  Hemorrhage  and
emoptysis  after  percutaneous  transthoracic  lung
iopsy occur  in  approximately  11%  and  up  to  7%,
espectively  as  reported  in  most  series  [38,57].
nusually  blood  emerging  from  the  hub  of  the  intro-
ucer needle  and  alveolar  hemorrhage  identiﬁed  on
he CT  scan  directly  as  perifocal  ground-glass  atten-
ation in  the  area  of  the  biopsy  or  along  the  needle
ract are  the  only  manifestations  of  bleeding  during
he procedure  but  should  be  considered  as  clues  to
he onset  of  hemoptysis.  It  is  more  likely  to  occur
n patients  with  abnormal  coagulation  or  pulmonary
rterial  hypertension.  Cutting  needles  especially
hose are  larger  than  18  gauge  are  associated  with
n increased  risk  for  hemorrhage  [10,27,40,58].
esion depth  especially  at  greater  than  2  cm  has
een identiﬁed  as  the  most  important  risk  factor
or hemorrhage  [59].  However,  other  lesions  risk
actors  include  size  smaller  that  2 cm,  vascularity,
avitations, presence  of  enlarged  bronchial  vessels
n the  vicinity,  and  central  location  [59,60].
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If  signiﬁcant  hemorrhage  occurs,  the  patient
hould be  placed  in  decubitus  position  with
he biopsy  side  down  to  prevent  transbronchial
spiration  of  blood.  However,  if  the  patient  is
emodynamically  unstable,  appropriate  supportive
anagement  with  ﬂuid  resuscitation  with  or  with-
ut blood  transfusion  is  required.  Rarely,  bronchial
r pulmonary  arterial  transcatheter  embolization  is
equired.
ir embolism
ir  embolism  is  the  most  severe  complications  but
t is  one  of  the  least  frequent  (0.07%)  [61,62].
t  occurs  when  air  enters  the  pulmonary  venous
ystem and  can  lead  to  systemic  air  embolism.
ir embolism  can  cause  myocardial  infarction,
rrhythmia, stroke  and  death.  Once  air  embolism
s suspected,  the  patient  should  be  placed  in  the
eft lateral  decubitus  position  or  in  Trendelenberg
osition to  prevent  residual  air  in  the  left  atrium
rom  entering  the  cerebral  circulation.  Supplemen-
al 100%  oxygen  should  be  administer  and  general
ymptomatic  support  should  be  provided  [10].
ew directions
andomized  evidence  suggests  that  the  technique
f biopsy  should  be  dropped  in  favor  of  image
uidance where  available  in  cases  of  suspected
ung lesion,  on  the  basis  of  higher  diagnostic  yield.
he choice  between  image  guidance  modalities
s largely  dependent  on  lesion  characteristics  on
T images  and  an  understanding  of  which  image-
uided  technique  will  be  safer.  Recently,  C-arm
one-beam CT  (CBCT)  with  a  ﬂat-panel  detector
ystem in  which  a cone-beam  X-ray  tube  and  a  ﬂat-
anel detector  are  integrated  with  a  C-arm  gantry
as been  developed  for  interventional  purposes
63]. It  has  both  CT  and  ﬂuoroscopy  image  capabil-
ties and  offers  greater  ﬂexibility  in  orientating  the
etector around  the  patient  than  closed  CT  gantry
ystems  in  addition  to  advanced  real-time  ﬂuoro-
copic and  three-dimensional  CT  capabilities  [64].
his image-guided  system  allows  identiﬁcation  of
he correct  trajectory  of  the  needle  to  the  lesion
nder real-time  ﬂuoroscopic  capability  and  veriﬁ-
ation of  the  exact  location  of  the  needle  tip  within
he target  lesion  using  the  CT  capability  of  the  sys-
em, thereby  improving  the  diagnostic  accuracy  and
fﬁcacy of  biopsy  and  enhancing  the  operator’s  con-
dence during  the  procedure.  Although  there  are
nly few  studies  about  CBCT-guided  percutaneous
ransthoracic  lung  biopsy,  the  reported  accuracy
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and  sensitivity  were  92%  and  94%,  respectively,
which are  comparable  CT-guided  percutaneous  lung
biopsy [65].
With  the  availability  of  speciﬁc  chemotherapy
and novel  targeted  therapy  for  lung  cancer,  the
core biopsy  should  provide  enough  material  for  both
diagnosis and  speciﬁcally  subtyping  of  malignancy.
As  some  of  the  tumors  show  histological  hetero-
geneity, particularly  with  regards  to  the  expression
of molecular  markers,  the  core  biopsies  should  be
obtained  from  different  parts  of  the  lesion  for  ade-
quate evaluation  of  this  heterogeneity.  Although
obtaining multiple  samples  with  using  cutting  nee-
dle and  coaxial  technique  is  a  potential  advantage,
substantial advantages  regarding  sensitivity  and
speciﬁcity  need  to  be  demonstrated  in  subsequent
larger studies.
Image-guided  percutaneous  transthoracic  lung
biopsy is  traditionally  and  technically  performed
by specialized  radiologists.  However,  a  multidis-
ciplinary approach,  including  oncologists,  radio-
logists,  pathologists,  thoracic  surgeons,  and/or
pulmonologists,  is  required  on  a  local  or  institu-
tional level  to  standardize  biopsy  protocols  for
obtaining  lung  tissue  with  regards  to  the  biopsy
technique used,  the  number  of  cores  obtained  and
the types  of  histopathologic  tests  applied  [3].  Such
a multidisciplinary  approach  should  be  adopted
whenever possible  as  it  will  help  to  fulﬁll  emerging
diagnostic requirements  for  the  use  of  novel  ther-
apies, avoid  thoracotomy  and  unnecessary  costs,
limit patient  stress  and  risks  associated  with  repeat
biopsies  due  to  inadequate  initial  obtained  samples
and optimize  patient  treatment.  Moreover,  it  will
facilitate  building  local  database  and  inclusion  of
patients in  speciﬁc  clinical  trials.
Conclusion
Image-guided  percutaneous  transthoracic  lung
biopsy especially  with  CT  guidance  is  generally  con-
sidered safe  technique  with  low  complications  rate
and a  high  diagnostic  yield  for  lung  cancer.  Various
imaging  modalities  have  been  used  for  guiding  the
percutaneous  transthoracic  lung  biopsy  based  on
lesion characteristics  on  CT  images  and  an  under-
standing  of  which  image-guided  technique  will  be
safer. Additionally,  radiologists  should  be  aware  of
the increasing  need  for  a  speciﬁc  histolopathologic
diagnosis in  order  to  optimize  patient  treatment  of
lung cancer  with  the  novel  therapies  and  achieve
the most  for  the  patient  care.
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